News

Puffy hands and fingers, as well as other symptoms, can precede the “warning sign” of Raynaud’s syndrome as the initial ...
Janet Pope, MD, MPH, discusses screening and diagnostic approaches for interstitial lung disease in patients with systemic ...
Patients with SSc vs controls showed a greater prevalence of WMH on brain MRIs, particularly in deep white matter regions.
A new interdisciplinary model for systemic sclerosis integrates imaging, AI, and personalized care to detect cardiac ...
Nearly half of patients with systemic sclerosis report symptoms of disordered eating, according to data published in ...
Novartis may have abandoned one Sjögren's syndrome asset this year, but it looks like the drugmaker has a winner on its hands ...
A new study finds nearly 50% of systemic sclerosis patients show signs of ARFID, raising concerns about disordered eating ...
Adicet Bio doses first systemic sclerosis patient in ADI-001 trial Company News Published 07/24/2025, 07:08 AM 0 ...
First patient treated in company-sponsored global basket trial exploring AlloNK® + rituximab in refractory rheumatoid arthritis, Sjögren’s disease, idiopathic inflammatory myopathies, and systemic ...
Ianalumab prolonged the duration of safe platelet levels during and after treatment in patients with primary immune thrombocytopenia (ITP) previously treated with corticosteroids1,2 Patients ...
REDWOOD CITY, Calif. & BOSTON, July 24, 2025--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for ...